Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(2009) In Human Molecular Genetics 18(20). p.3942-3954- Abstract
- Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG-expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular beta-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing beta-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using... (More)
- Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG-expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular beta-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing beta-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and beta-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from beta-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1452862
- author
- organization
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Human Molecular Genetics
- volume
- 18
- issue
- 20
- pages
- 3942 - 3954
- publisher
- Oxford University Press
- external identifiers
-
- wos:000270218300014
- pmid:19628478
- scopus:70349569018
- pmid:19628478
- ISSN
- 0964-6906
- DOI
- 10.1093/hmg/ddp336
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Molecular Metabolism (013212001), Islet cell physiology (013212142), Translational Neuroendocrinology (013210010), Connective Tissue Biology (013230151), Neuronal Survival (013212041), Insulin Signal Transduction (013212014), Department of Experimental Medical Science (013210000)
- id
- f2a5db26-a504-471d-bf00-964879dabeda (old id 1452862)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/19628478?dopt=Abstract
- date added to LUP
- 2016-04-01 11:34:01
- date last changed
- 2023-08-31 23:04:42
@article{f2a5db26-a504-471d-bf00-964879dabeda, abstract = {{Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG-expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular beta-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing beta-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and beta-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from beta-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein.}}, author = {{Smith, Ruben and Bacos, Karl and Fedele, Valentina and Soulet, Denis and Jones, Helena and Obermüller, Stefanie and Lindqvist, Anders and Björkqvist, Maria and Klein, Pontus and Önnerfjord, Patrik and Brundin, Patrik and Mulder, Hindrik and Li, Jia-Yi}}, issn = {{0964-6906}}, language = {{eng}}, number = {{20}}, pages = {{3942--3954}}, publisher = {{Oxford University Press}}, series = {{Human Molecular Genetics}}, title = {{Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.}}, url = {{http://dx.doi.org/10.1093/hmg/ddp336}}, doi = {{10.1093/hmg/ddp336}}, volume = {{18}}, year = {{2009}}, }